Closing the Gaps to Timely Patient Access: Perspectives on Conditional Funding Models

The Canadian system for approval of new cancer drugs is complex with multiple steps. Health Canada grants a license for a drug to be marketed and prescribed. The Canadian Agency for Drugs and Technologies in Health (CADTH) and Institut national d’excellence en santé et services sociaux (INESSS) make...

Full description

Bibliographic Details
Main Authors: Judith Glennie, Eva Villalba, Paul Wheatley-Price
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/2/83